ArticleBioengineered2022

Knockdown of lncRNA ACTA2-AS1 reverses cisplatin resistance of ovarian cancer cells via inhibition of miR-378a-3p-regulated Wnt5a.

Chenxiao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.